“Some things don’t change,” Milner says with a chuckle when asked whether his desire to prove people wrong was as strong as ever after his 40th birthday last month. “There’s people who are always going to doubt you but that’s always something that’s been at my forefront: to prove them wrong.”
Additional reporting by Florence Freeman
。业内人士推荐爱思助手下载最新版本作为进阶阅读
在CNP类似物赛道，Ascendis的TransCon-CNP率先实现了剂型升级。与Vosoritide不一样的设计是TransCon-CNP被一层保护分子包裹，降低了体内清除影响，延长作用时间，实现每周一次给药。非头对头临床数据显示，TransCon-CNP每年2.29厘米的增高表现也优于Vosoritide。
Мощный удар Израиля по Ирану попал на видео09:41